Navigation Links
Treatment Available for Macular Degeneration Low Vision in Connecticut
Date:4/23/2013

DANBURY, Conn., April 23, 2013 /PRNewswire-iReach/ -- Prismatic Magnifying Readers (PMRs) can often help people with macular degeneration, glaucoma, diabetic retinopathy and others with low vision who are having difficulty reading by providing extra magnification and comfort.  The most common vision loss for someone with low vision is the reduced ability to read.

Dr. Randolph Kinkade , a Connecticut optometrist and founding member of the International Academy of Low Vision Specialists, has coined the new term Prismatic Magnifying Readers to describe the design and purpose behind these beneficial low vision glasses.

Prismatic Magnifying Readers, when combined with enhanced illumination, often improve reading ability.  Individuals whose vision is in the range of 20/50 to 20/200 and is relatively equal in both eyes can benefit from PMRs.

"The prism enables material to be held at a closer reading distance allowing for more magnification and comfort", said Dr. Kinkade.  "The prism improves binocular viewing which in turn improves the reading field of view.  Words are not only larger, but more words can be seen at a time."

Holding reading material close (closer than 16") creates the magnification.  The closer the reading material is held to the eyes the more the focusing magnification can be created by the glasses.  For example, when reading material is held at 8" from the eyes 2X magnification is created compared to when the same material was held at 16" (a normal reading distance).  When the material is held at 4" from the eyes 4X magnification is generated.  Bigger is better for people with low vision.

Lens strength is usually measured in the optical term "diopters" which is different than "magnification power".   The more diopters in the prescription the closer the reading material must be held to the eyes.

"The prism is designed to reduce binocular eye fatigue and reading stress", said Dr. Kinkade.  "The closer the book is held to the eyes, the more the eyes must turn in for binocular viewing.  Without prism, there is a limit to how much the eyes can naturally and comfortably turn in."

There are also limits to the amount of prism that can be beneficial in a prescription.  Twelve units of prism in each eye is often the practical limit.   At a 4" viewing distance patients may be better off reading with one eye; the best eye.  At this point the prescription is changed from PMRs to monocular microscopic glasses (very high power for one eye only).

Pictures of Prismatic Magnifying Readers, educational videos, and television interviews are available at LowVisionEyeglasses.com.

Dr. Kinkade has offices throughout Connecticut.  He can be contacted at (800) 756-0766 and at rkinkade@optonline.net.

About Macular Degeneration

Macular degeneration is usually an age-related eye disease that can result in considerable vision loss. It occurs when the macula, or center part of the retina providing 20/20 vision, begins to breakdown.

The macula is an extremely important part of the retina used for seeing. It allows us to focus and carry out many vision related duties like reading, writing, driving and crafts. The macula is essential for crisp detail vision.

Dry macular degeneration is considered the most common (80-90%) and consists of yellow deposits (drusen) developing in the macula. In dry macular degeneration, blind spots develop within the line of vision. The decrease in vision is usually gradual and takes many years to develop. There is not effective treatment for this form of the disease.

Wet macular degeneration is more prone to rapid and severe vision loss if not treated. In this condition blood vessels develop and leak fluid behind the macula. Current treatment involves a series of injections to stop the vessels from developing.



Media Contact:

Randolph Kinkade , OD, MPH Low Vision Consulting, (800) 756-0766, rkinkade@optonline.net



News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Low Vision Consulting
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. For Treatment of Extensive-Disease Small-Cell Lung Cancer (ED-SCLC), No Emerging Therapy is Likely to Replace Etoposide/Carboplatin as the Standard of Care Before 2022
2. Cancer Experts Detail Advanced Radiosurgery Treatments for Lung Cancer Using Varian Medical Systems Technologies
3. Significant Unmet Medical Need for Treatment of Patients with Chronic Pain with Dysphagia (CPD)
4. Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection
5. Results of Pediatric Clinical Trial of External Trigeminal Nerve Stimulation for the Treatment of ADHD
6. Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients
7. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
8. ARMGO Pharma Receives $1 Million Award from MDA to Support Advancement of Rycal Compound ARM210 as a Novel Treatment for Duchenne Muscular Dystrophy
9. FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
10. Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems
11. Electrical pulse treatment pokes holes in hard-to-treat tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016  The Senior Care Pharmacy Coalition ... Committee Chairman Jason Chaffetz (R-UT) and ... hearing , "Developments in the Prescription Drug ... growing questions about abusive pharmacy benefit manager (PBM) ... and Ranking Member Elijah Cummings (D-MD) are diligent, ...
(Date:2/4/2016)... , Feb. 4, 2016   Bernstein Liebhard LLP ... in the United States District Court for the District of ... (the "Class") consisting of all persons or entities who purchased ... (NASDAQ: INSY ) from March 3, 2015 through January ... certain of its officers with violations of the Securities Exchange ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
Breaking Medicine Technology:
(Date:2/8/2016)... KS (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com ... leader in Mole removal products. , Moles are derived from a cluster of melanin ... in all the wrong places and create a lifetime of embarrassment. Historically, mole ...
(Date:2/8/2016)... ... 08, 2016 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase patient awareness of ... Your Mouth?” campaign to inform dentists and patients about the possible lack of ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... Plastics, has added Kybella® to his medical and surgical expertise. Technically known as ... FDA injectable medication used as a non-surgical alternative for reduction of fat below ...
(Date:2/6/2016)... St. Petersburg, FL (PRWEB) , ... February 06, 2016 , ... ... AsSeenOnTV.pro are pleased to announce the launch of a new DRTV campaign with Belly ... rug. If having tried everything from sprays to puppy pads and find nothing works, ...
(Date:2/5/2016)... ... 05, 2016 , ... VeloReality President and co-founder ... LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience at the ... reduce the weight of the unit, they also enhance the rider's experience with ...
Breaking Medicine News(10 mins):